Biomarin

Orphan drugmaker ViroPharma attracts takeover interest: sources
Reuters
Mon, 06/17/13 - 11:52 am
ViroPharma
M&A
Biomarin
BioMarin's cancer drug success prompts launch of pivotal trial
Reuters
Mon, 06/3/13 - 12:34 pm
Biomarin
BMN673
breast cancer
ovarian cancer
FDA delays review of BioMarin's Vimizim by three months
The Fly on the Wall
Thu, 05/30/13 - 11:33 am
Vimizim
FDA
Biomarin
BioMarin Gains on Prospects for Experimental Cancer Drug
Bloomberg
Thu, 05/23/13 - 11:49 am
Biomarin
Ewing's sarcoma
BMN-673
breast cancer
ovarian cancer
small cell lung cancer
BioMarin abstract showed impressive anti-tumor activity, says Leerink
Yahoo/Fly on the Wall
Thu, 05/16/13 - 10:28 am
Biomarin
BMN-673
solid tumors
Orphan Drug Biotechs Do It Best
Motley Fool
Fri, 04/19/13 - 12:14 pm
orphan drugs
Alexion
Biomarin
Vertex Pharmaceuticals
These 4 'High-Potential' Biotech Stocks Could Outperform In 2013
Seeking Alpha
Thu, 04/18/13 - 06:57 pm
Arena Pharmaceuticals
Gilead
Biomarin
Acadia
Catalyst Pharmaceutical Partners
BioMarin submits CTA for BMN-190 for Batten disease
Yahoo/Fly on the Wall
Mon, 04/1/13 - 10:59 am
Biomarin
BMN-190
Batten disease
BioMarin: Gains To Continue As Pipeline Progress Is Realized
Seeking Alpha
Mon, 03/25/13 - 12:15 pm
Biomarin
BioMarin says it will continue studies of late-onset Pompe disease drug candidate BMN-701
Yahoo/AP
Wed, 03/20/13 - 12:26 pm
Biomarin
Pompe disease
BMN-701
4 Biotech Stock Stars Losing Their Luster
TheStreet.com Stockpkr
Thu, 02/21/13 - 12:06 pm
Celgene
Biogen Idec
Life Technologies
Biomarin
BioMarin Earnings: An Early Look
Motley Fool
Tue, 02/19/13 - 03:14 pm
earnings
Biomarin
Biomarin: This Mid-Cap Pharmaceutical is a Prime Takeover Target
Motley Fool
Mon, 02/18/13 - 11:57 am
M&A
Biomarin
Sanofi
Genzyme
This Mid-Cap Pharmaceutical is a Prime Takeover Target
Motley Fool
Sat, 02/16/13 - 11:36 am
Biomarin
BioMarin Pharmaceuticals Inc: Today's Featured Health Care Winner
The Street
Sat, 02/16/13 - 11:24 am
Biomarin
Six Things to Watch at Biotech CEO Conference
Minyanville
Mon, 02/11/13 - 11:10 am
BIO CEO Conference
ONYX Pharmaceuticals
Celgene
Gilead
Biomarin
Eli Lilly
Keryx
Arena Pharmaceuticals
Orexigen
Banking on Biotech
CNBC
Sat, 01/12/13 - 10:33 am
Regeneron
Biogen Idec
Acorda Therapeutics
Sanofi
Celgene
Alexion
Biomarin
NPS Pharmaceuticals
Cerner
EXACT Sciences
Pfizer
Bristol-Myers Squibb
Eli Lilly
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
BioMarin's Expanding Product Portfolio Will Lead To Gains In 2013
Seeking Alpha
Mon, 12/31/12 - 10:42 am
Biomarin
GSK
Sanofi
1 Event That Could Make or Break Biotech Stocks
Motley Fool
Thu, 12/6/12 - 10:50 am
Halozyme
Isis Pharmaceuticals
Biomarin
Bristol-Myers Squibb
Sarepta

Pages